D. E. Shaw & Co., Inc. Deciphera Pharmaceuticals, Inc. Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$13.58 - $17.36 $1.6 Million - $2.04 Million	117,721 Added 30.29%	506,384 $7.97 Million
Q4 2023 Feb 14, 2024	BUY	$10.11 - $16.54 $724,907 - $1.19 Million	71,702 Added 22.62%	388,663 $6.27 Million
Q3 2023 Nov 14, 2023	SELL	$12.46 - $15.48 $808,043 - $1 Million	-64,851 Reduced 16.99%	316,961 $4.03 Million
Q2 2023 Aug 14, 2023	SELL	$13.28 - $15.96 $5.43 Million - $6.53 Million	-408,974 Reduced 51.72%	381,812 $5.38 Million
Q1 2023 May 15, 2023	SELL	$14.26 - $22.1 $2.96 Million - $4.59 Million	-207,707 Reduced 20.8%	790,786 $12.2 Million
Q4 2022 Feb 14, 2023	BUY	$14.85 - $19.04 $3.09 Million - $3.96 Million	208,082 Added 26.33%	998,493 $16.4 Million
Q3 2022 Nov 14, 2022	BUY	$12.38 - $20.23 $7.72 Million - $12.6 Million	623,526 Added 373.63%	790,411 $14.6 Million
Q2 2022 Aug 15, 2022	BUY	$9.11 - $13.98 $938,248 - $1.44 Million	102,991 Added 161.19%	166,885 $2.2 Million
Q1 2022 May 16, 2022	SELL	$6.87 - $11.11 $522,216 - $844,515	-76,014 Reduced 54.33%	63,894 $592,000
Q4 2021 Feb 14, 2022	BUY	$7.7 - $37.13 $946,830 - $4.57 Million	122,965 Added 725.76%	139,908 $1.37 Million
Q4 2020 Feb 16, 2021	BUY	$51.77 - $66.18 $306,530 - $391,851	5,921 Added 53.72%	16,943 $967,000
Q3 2020 Nov 16, 2020	SELL	$43.8 - $58.16 $438,131 - $581,774	-10,003 Reduced 47.58%	11,022 $565,000
Q2 2020 Aug 14, 2020	BUY	$37.05 - $65.03 $654,821 - $1.15 Million	17,674 Added 527.42%	21,025 $1.26 Million
Q4 2019 Feb 14, 2020	SELL	$31.7 - $69.93 $1.09 Million - $2.4 Million	-34,338 Reduced 91.11%	3,351 $209,000
Q3 2019 Nov 14, 2019	BUY	$19.95 - $38.85 $751,895 - $1.46 Million	37,689 New	37,689 $1.28 Million
Q3 2018 Nov 14, 2018	SELL	$33.57 - $42.1 $309,884 - $388,625	-9,231 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$20.06 - $44.95 $185,173 - $414,933	9,231 New	9,231 $363,000

Others Institutions Holding DCPH

# of Institutions

Shares Held

293K

Call Options Held

500

Put Options Held

View Full List

About Deciphera Pharmaceuticals, Inc.

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

More about DCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account